VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
trimethoprim-sulfamethoxazole or doxycycline
Preclinical
Small molecule
U
University of Texas Southwestern Medical Center
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Soft Tissue Infections
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Soft Tissue Infections
Preclinical
Completed
Clinical
Trials by Indication
[1]
Soft Tissue Infections
1 trial
Trimethoprim-Sulfamethoxazole or Doxycycline for Skin and Soft Tissue Infections
Completed
·
U
University of Texas Southwestern Medical Center
·
N/A
·
NCT00428818
·
75 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for trimethoprim-sulfamethoxazole or doxycycline. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
trimethoprim-sulfamethoxazole or doxycycline compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for trimethoprim-sulfamethoxazole or doxycycline. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
University of Texas Southwestern Medical Center company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
U
University of Texas Southwestern Medical Center
Related News